IBA begins distribution of I-124 MIBG

Ion Beam Applications (IBA), of Louvain-la-Neuve, Belgium, has begun worldwide distribution of iodine-124 meta-iodobenzlguanidine (I-124 MIBG) through its U.S. subsidiary Eastern Isotopes in Sterling, VA.

The PET radiopharmaceutical I-124 MIBG currently is for investigational purposes. MIBG has been used for evaluating the cardiac symptomatic nervous system and the diagnosis, treatment planning, and radiotherapy of various neuroendocrine malignancies, according to IBA.

By AuntMinnie.com staff writers
November 29, 2005

Related Reading

Eastern Isotopes buys Cyclo-Tech, November 7, 2005

Eastern Isotopes expands FDG operations, September 2, 2005

New Premier contract for Eastern Isotopes, May 19, 2005

IBA adds radiopharmacies, January 21, 2005

Copyright © 2005 AuntMinnie.com

Page 1 of 436
Next Page